The reasons I won't sell my DOSE shares (& plan to buy more)Regardless of the retail expansion...
Despite the filing delays...
The research collaboration with McMaster University (a credible institution) has the potential to introduce a disruptive product:
- A vaccine strip that can solve the vaccine delivery & logistics issue, without the need of expensive cold storage distribution & no-needle injections.
- We're not just talking about Covid, but a viable drug delivery alternative for the pharmaceutical industry in general.
- It's a scalable product with indications for use worldwide.
- The research has already presented positive results. Further progress in research will likely result in media exposure/announcement (potentially resulting in an uptrend spike)
- One of 5 Canadian companies accepted into the Venture Mentoring Services (US/CAN) collaboration. If there wasn't aat least a viable business model, they would not have been selected.